Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01295 |
| Species: | Homo sapiens |
| Position : | chr8:128805000-128807000 |
| Year: | 2025 |
| Title: | Mechanisms of enhancer-driven oncogene activation in human cancers |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | colorectal carcinoma |
| PMID: | 39853740 |
| MONDO: | MONDO:0005132 |
| Tissue: | Colon |
| Tissue Ontology ID: | UBERON:0001155 |
| Cell Source: | COLO 320DM cells |
| CVCL ID: | CVCL_0219 |
| Cell Type: | colorectal carcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | Hi-C, ChIP-seq, RNA-seq |
| Low Throughput Method: | Luciferase reporter assay, CRISPRi |
| Target gene : | MYC |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|